Clinical Trial

Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC

Study acronym: PROTECT-NPC
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study is a multicenter, non-inferiority, open-label, randomized controlled Phase III clinical trial. It aims to compare the efficacy of modified delineation radiotherapy (experimental group) versus standard delineation radiotherapy (control group) in the prophylactic irradiation of neck lymphatic drainage areas III/IVa in nasopharyngeal carcinoma. The study evaluates the incidence of primary hypothyroidism, quality of life, and adverse events between the two groups.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-27; most recent amendment 2025-04-08.
Status change: Not Yet Recruiting → Recruiting 2025-04-07
Trial Details
NCT Number NCT06752239
Lead Sponsor Jiangxi Provincial Cancer Hospital
Conditions Nasopharyngeal Carcinoma, Quality of Life, Thyroid Diseases, Radiotherapy Side Effect, Radiotherapy
Enrollment 474 participants
Start Date 2025-01-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2031-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-10